We Want Your Feedback: Public Comment Period Ends Next Week (Feature Topic 2: Recalls)
On May 19, the Transparency Task Force released 21 draft proposals about information FDA should consider making available to the public. (see previous blog post). The time to provide the Task Force with your feedback on these draft proposals ends next Tuesday, July 20.
The second topic being featured for your input is Recalls. The draft proposals are about the following issues:
- When a system is set up that provides FDA with the authority to require companies to submit certain information about recalled products to FDA, disclosing this information after FDA recieves it from the firm. Click here to comment on and rate the proposal. You can read the draft proposal, FDA's reason for the proposal, and other comments submitted so far.
- Supporting efforts to address confusion in the marketplace about products that may be implicated in a food outbreak. Click here to comment on and rate the proposal. You can read the draft proposal, FDA's reason for the proposal, and other comments submitted so far.
- Disclosing when a product recall is terminated. Click here to comment on and rate the proposal. You can read the draft proposal, FDA's reason for the proposal, and other comments submitted so far.
The Task Force is asking for your feedback on the content of the draft proposal and on which proposal(s) should be given priority.
The entire report is available on the FDA Web site. Visit the web site, read the report, and comment there about any of the 21 draft proposals. You can also submit a comment here.
We look forward to your input.
Afia Asamoah
FDA Transparency Initiative Coordinator
FDA is also looking for public comments on FDA-TRACK, a new agency-wide program performance management system that monitors over 100 FDA program offices through key performance measures. FDA-TRACK went live several weeks ago as part of the Transparency Initiative.
http://www.frontlinecom.co.uk/
I’m sending a last minute note to you about Avandia. I should have written to you sooner. I was taking Avandia in 2001 and took it for a few years. In 2005 I ended up in surgery for a triple bypass. I am now being treated for congestive heart failure and hopefully a stroke is not around the corner. I have been changed to Actos and I really hope you take Avandia off the market. Thank you, Mia
FDA information should consider making available to the public,When a system is set up that provides FDA with the authority to require companies to submit certain information about recalled products to FDA, disclosing this information after FDA recieves it from the firm,nice and informative article, Thanks for this information.
FDA is also looking for public comments on FDA-TRACK, a new agency-wide program performance management system that monitors over 100 FDA program offices through key performance measures. FDA-TRACK went live several weeks ago as part of the Transparency Initiative.
Iraqi Dinar
I have liked your thoughts, I am going to subscribe your blog and will come here again
to know more. thanks,
Your discussion is exactly the same i agree for . I will scribe your blog and will come back.
Dinar Iraqi
Great communication between government and the citizens. This blog is a good example and I go to refer it in my blog as a exmple to follow in my small caountry.
Great communication between government and the citizens. This blog is a good example and I go to refer it in my blog as a exmple to follow in my small country.